Hepatitis C Drug Market Investment Opportunities and Commercial Outlook 2032
The global hepatitis C drug market was valued at USD 7.86 billion in 2018 and is expected to grow to USD 9.84 billion by 2032, registering a compound annual growth rate (CAGR) of 1.8% over the forecast period from 2018 to 2032. In 2018, North America led the market, accounting for 47.46% of the global share.
-
Follow
-
0
-
Embed
-
Share
-
Upload
